Review of cancer cell resistance mechanisms to apoptosis and actual targeted therapies
- 17 November 2021
- journal article
- review article
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 123 (11) , 1736-1761
Abstract
The apoptosis pathway is a programmed cell death mechanism that is crucial for cellular and tissue homeostasis and organ development. There are three major caspase‐dependent pathways of apoptosis that ultimately lead to DNA fragmentation. Cancerous cells are known to highly regulate the apoptotic pathway and its role in cancer hallmark acquisition has been discussed over the past decades. Numerous mutations in cancer cell types have been reported to be implicated in chemoresistance and treatment outcome. In this review, we summarize the mutations of the caspase‐dependant apoptotic pathways that are the source of cancer development and the targeted therapies currently available or in trial.Keywords
Funding Information
- Natural Sciences and Engineering Research Council of Canada (operating grant 1257509)
This publication has 259 references indexed in Scilit:
- Signaling Pathways from the Endoplasmic Reticulum and Their Roles in DiseaseGenes, 2013
- Evaluation of pharmacodynamic biomarkers in a Phase 1a trial of dulanermin (rhApo2L/TRAIL) in patients with advanced tumoursBritish Journal of Cancer, 2011
- Bcl-xL Retrotranslocates Bax from the Mitochondria into the CytosolCell, 2011
- Downregulation of autophagy by Bcl-2 promotes MCF7 breast cancer cell growth independent of its inhibition of apoptosisCell Death & Differentiation, 2010
- IRE1α controls cyclin A1 expression and promotes cell proliferation through XBP-1Cell Stress and Chaperones, 2010
- An Alternative Splicing Network Links Cell-Cycle Control to ApoptosisCell, 2010
- Cellular FLICE-inhibitory protein (c-FLIP) signalling: A key regulator of receptor-mediated apoptosis in physiologic context and in cancerThe International Journal of Biochemistry & Cell Biology, 2010
- Death through a tragedy: mitotic catastropheCell Death & Differentiation, 2008
- The Differentiation and Stress Response Factor XBP-1 Drives Multiple Myeloma PathogenesisCancer Cell, 2007
- Molecular cloning and expression of the fas ligand, a novel member of the tumor necrosis factor familyCell, 1993